Prevalence of HIV and TB Co-infection: Mumbai Scenario
Parole chiave:
HIV, TB, coinfection, nucleic acid amplificationAbstract
HIV, being the most powerful risk factor, has made the reappearance and progression of tuberculosis easier. The partnership of HIV and TB is a major health problem in both developed and developing countries. The present study was undertaken in Mumbai to study the prevalence of HIV and TB coinfection in patients who visited the tertiary care centers in the city. Both HIV and TB were diagnosed using nucleic acid amplification technique. Blood samples were collected for the detection of HIV, whereas for TB detection three consecutive days of sputum samples were collected. Statistical analysis was carried out by applying the Chi-square test to determine the prevalence of the HIV and TB coinfection. A total of 1725 suspected patients were screened for both HIV and TB, of which 784 were females and 942 were males. Of the total patients screened, 38.81% were found to be positive for both HIV and TB, among whom 15.8% were females and 23% were males. It was also found that the HIV and TB coinfection was predominant in the age group of 21 to 40 years which was found to be statistically significant (p < 0.05). TB and HIV have been closely linked with each other creating a deep impact on the global epidemiology of tuberculosis. Incidence of HIV/TB coinfection in India is still progressing though globally there is an overall decline. The referral system concerning care and support mechanism for HIV-TB patients shall be made a two-way system incorporating the responsibility and accountability for treatment completion, and sharing of information on treatment. Keywords: HIV, TB, coinfection, nucleic acid amplificationPubblicato
Fascicolo
Sezione
Licenza
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |